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Abstract—In recent years, with the growing amount of biomed-
ical documents, coupled with advancement in natural language
processing algorithms, the research on biomedical named en-
tity recognition (BioNER) has increased exponentially. However,
BioNER research is challenging as NER in the biomedical domain
are: (i) often restricted due to limited amount of training data,
(ii) an entity can refer to multiple types and concepts depending
on its context and, (iii) heavy reliance on acronyms that are
sub-domain specific. Existing BioNER approaches often neglect
these issues and directly adopt the state-of-the-art (SOTA) models
trained in general corpora which often yields unsatisfactory
results. We propose biomedical ALBERT (A Lite Bidirectional
Encoder Representations from Transformers for Biomedical Text
Mining) bioALBERT an effective domain-specific language
model trained on large-scale biomedical corpora designed to
capture biomedical context-dependent NER. We adopted a self-
supervised loss used in ALBERT that focuses on modelling
inter-sentence coherence to better learn context-dependent rep-
resentations and incorporated parameter reduction techniques
to lower memory consumption and increase the training speed
in BioNER. In our experiments, BioALBERT outperformed
comparative SOTA BioNER models on eight biomedical NER
benchmark datasets with four different entity types. We trained
four different variants of BioALBERT models which are available
for the research community to be used in future research.
I. INTRODUCTION
The growing volume of the published biomedical literature,
such as clinical reports [1] and health literacy [2], are fu-
elling the advancements in the development of text mining
algorithms. Biomedical named entity recognition (BioNER)
intends to automatically identify biomedical entities such
as diseases, chemicals, genes and proteins, etc., from the
biomedical literature. So, a crucial step towards this aim is
to build better and effective methods which can automati-
cally recognize and extract biomedical entities. BioNER is
an essential building block of many downstream text mining
applications such as extracting drug-to-drug interactions [3]
and disease-treatment [4] relationships. Traditionally, BioNER
relies on feature engineering methods (e.g., lexicon-based,
rules-based and statistics-based). However, feature engineering
is dependent on domain-specific knowledge which does not
perform well on BioNER [5].
Deep learning (DL) with its ability to automatically extract
features have become common in BioNER recently [6]. For
instance, Long Short-Term Memory (LSTM) is usually em-
ployed to learn vector representations of each word in a sen-
tence, and then as the input to conditional random fields (CRF)
have greatly improved the performance in BioNER [6]. Re-
cently state-of-the-art (SOTA) DL based language models such
as Embeddings from Language Models (ELMo) [7], Bidirec-
tional Encoder Representations from Transformers (BERT) [8]
and (A Lite Bidirectional Encoder Representations from Trans-
formers (ALBERT) [9] obtained SOTA best performance on
many NLP tasks.
Although these models show promising results, but applying
them on BioNER has multiple challenges and limitations: (i) a
limited amount of training data; (ii) an entity could represent
multiple entity types depending on its textual context, i.e., a
BRCA1 can be referred as gene name as well as a disease
entity depending on its context. Similarly, heart attack and
myocardial infarction refer to the same concept and, (iii)
the heavy use of acronyms in biomedical texts makes it
challenging to identify concepts, i.e., the abbreviation RA
may refer to right atrium, rheumatoid arthritis, or one of
several other concepts, where the resolution of the abbreviation
is, therefore, context-dependent. Therefore, current models in
BioNER rely on various context-independent and transformer-
based context-dependent language models which are trained
on biomedical corpora [10]–[12].
To overcome the identified limitations, we present Biomed-
ical ALBERT bioALBERT - a context-dependent, fast and
effective language model that addresses the shortcomings of
recently proposed domain-specific language models. BioAL-
BERT is trained on large biomedical corpora which address
the limitation of limited training data. We also innovate in the
adoption of cross-layer parameter sharing by learning param-
eters for the first block and reuse the block in the remaining
layers instead of learning unique parameters for each of the
layers and sentence-order-prediction (SOP) technique as a
measure of coherence loss between sentences. SOP takes two
consecutive sentences from training data and creates a random
pair from different sentences which helps the model to learn
better representations and finally, in BERT based models the
size of the embedding was linked to the hidden layer sizes
of the transformer blocks. These embeddings are projected
directly to the hidden space of the hidden layer whereas
in our model we use factorized embedding parameterization
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Fig. 1: Overview of the pre-training and fine-tuning of BioALBERT on NER
which decomposes embedding matrix into two small matrices
which separate the size of the hidden layers from the size
of vocabulary embeddings. This allows for increasing the
hidden size without significantly increasing the parameter
size of the vocabulary embeddings. BioALBERT is simple
and efficient when fine-tuned for BioNER task as compared
to other SOTA models. We evaluate our model on eight
biomedical named entity recognition benchmark datasets. Our
pre-trained BioNER models, along with the source code, will
be publicly available.
II. RELATED WORK
A. Language Model
In biomedical text mining research, there is a long history
of using shared language representations to capture the se-
mantics of the text. One established trend is a form of word-
embeddings [13] that represent syntactic and semantic mean-
ing, and map words into low-dimensional vectors. Similar
methods also have been derived for improving embeddings
of word sequences by introducing sentence embeddings [14].
These context-independent word embeddings approach such
as word2vec [13] were trained on biomedical corpora that
contain terms and expressions that are usually not included in
a general domain corpus [10]. These methods always require
complex neural networks to be effectively used and model
context-independent representations.
Another common trend, particularly in recent years, is text
representation based on context [7]–[9]. Unlike traditional
word-embeddings, this enables a word to change its meaning
depending on the context in which it occurs. Several other
works have investigated the usefulness of contextual models in
clinical and biomedical domains. Several researchers trained
ELMo on biomedical corpora and presented BioELMo and
found that BioELMo beats ELMo on BioNER tasks [11], [16].
A pre-trained BioELMo model was released along with their
work, allowing more clinical research in the area of BioNER.
Beltagy et al. [15] released Scientific BERT (SciBERT), where
BERT was trained on the scientific texts. BERT has typically
been superior and better than ELMo to non-contextual embed-
dings.
Si et al. [17], trained the BERT on clinical notes corpora,
using complex task-specific models to improve both traditional
embedding and ELMo embedding on the i2b2 2010 and 2012
BioNER. Similarly in another study, a new domain-specific
language model, BioBERT [12], trained a BERT model on a
corpus of biomedical articles from PMC abstracts1 as well as
full texts sourced from PubMed2 which gave rise to enhanced
performance on BioNER. Peng et al [18] introduced Biomedi-
cal Language Understanding Evaluation (BLUE), a collection
of resources for evaluating and analysing biomedical natural
language representation models. Their study also confirmed
that the BERT models pre-trained on PubMed abstracts and
clinical notes see better performance than most state-of-the-art
models.
Despite this success, BERT has some limitations such as
BERT has a huge number of parameters which is the cause
for problems like degraded pre-training time, memory man-
agement issues and model degradation etc [9]. These issues
are very well addressed in ALBERT, which is modified based
on the architecture of BERT and proposed by Lan et al. [9].
ALBERT incorporates two-parameter reduction techniques
that lift the significant obstacles in scaling pre-trained models.
(i) Factorized embedding parameterization - decomposes the
large vocabulary embedding matrix into two small matrices,
(ii) replaces the NSP loss by SOP loss; and (iii) Cross-layer
parameter sharing- prevents the parameter from growing with
the depth of the network. These techniques significantly reduce
the number of parameters used when compared with BERT
without significantly affecting the performance of the model,
thus improving parameter-efficiency. An ALBERT configura-
tion similar to BERT-large has 18x fewer parameters and can
be trained about 1.7x faster.
B. Fine tuning
Fine-tuning has been successfully used to transfer pre-
trained weights as initialisation for parameters for various
downstream tasks [19]. This improves the efficiency of the
1https://www.ncbi.nlm.nih.gov/pmc/
2https://www.ncbi.nlm.nih.gov/pubmed/
TABLE I: Summary of parameters used in the Pre-training
Summary of All parameters used: (Pre-Training)
Name BioALBERT 1.0 BioALBERT 1.1
Architecture ALBERT Base ALBERT Large
Activation function GeLU GeLU
Number of Attention Heads 12 16
Number of layers 12 24
Hidden Size 768 1024
Embedding Size 128 128
Vocab Size 30000 30000
Optimizer LAMB LAMB
Train Batch Size 1024 256
Eval Batch Size 16 16
Max Seq Length 512 512
Max Predictions per Seq 20 20
Learning Rate 0.00176 0.00062
Training Steps (PubMed) 200K 200K
Training Steps (PMC) 270K 270K
Warmup Steps 3125 3125
target task when we have limited data and similar tasks [20].
Recently, fine-tuning of pre-trained language models have been
widely used in various text mining tasks [21]. Liu et al. [22]
pre-trained LSTM with a language model and fine-tuned it,
and this has contributed to improved performance for various
text classification tasks.
Universal Language Model Fine-tuning (ULMFiT) used
general-domain pre-training and fine-tuning techniques to
avoid over-fitting and achieved SOTA performance on the
datasets with less samples [19]. Similarly, authors of BERT,
ALBERT, BioBERT and others tested the performance of
their model for a wide range of tasks with minimum fine-
tuning efforts and achieved good performance. Recently, multi-
task fine-tuning has led to improvements even with many
target tasks [23]. In this paper, we fine-tuned our pre-trained
language model BioALBERT, which is trained on biomedical
corpora for BioNER. BioALBERT offers better performance
on BioNER as it addresses the shortcomings of BERT used
in BioBERT. However, this is not a trivial task as it requires
several optimisations which are discussed in the next section.
Weights of our pre-trained model along with complete source
code, will be available online.
III. METHODOLOGY
First, we initialized BioALBERT with weights from AL-
BERT. BioALBERT is pre-trained on biomedical domain
corpora (PubMed abstracts and PMC full-text articles). To
show the effectiveness of our approach, BioALBERT is fine-
tuned on BioNER. We tested various pre-training strategies
with different combinations and sizes of biomedical corpora.
The overview of our methodology is shown in Fig. 1. Below
we present details of each step involved in pre-training and
fine-tuning of BioALBERT.
A. Pre-training of BioALBERT
In this section, we present steps involved in the pre-training
of BioALBERT, which has the same architecture as ALBERT,
which makes it simple. BioALBERT is trained on PubMed
abstracts and PMC full-text articles which contains biomedical
TABLE II: BioALBERT Pre-trained Models
Model Version Model Trained On # of words Machine Used Batch Size Steps
BioALBERT 1.0 Base PubMed 4.3B GCP TPU v3-8 1024 200K
BioALBERT 1.0 Base PubMed+PMC 18.8B GCP TPU v3-8 1024 470K
BioALBERT 1.1 Large PubMed 4.3B GCP TPU v3-8 256 200K
BioALBERT 1.1 Large PubMed+PMC 18.8B GCP TPU v3-8 256 470K
terms and enables to pre-train the ALBERT model, which
was pre-trained on the general text on biomedical corpora.
As we cannot use the raw text biomedical corpora (PubMed
and PMC) to pre-train the model, so we converted raw text
to structured format by converting raw text files into a single
sentence in which; (i) all blank lines are removed within a
document and converted it into on single paragraph; (ii) Any
line less than 20-character length is removed and (iii) there
will be a blank line between each document (when combining
the multiple files) for training the model. Overall, PubMed
contains approximately 4.5 Billion words, and PMC contains
about 13.5 Billion words. As an initial step, we have initialized
the model weights from ALBERT to create BioALBERT
model by pre-training on biomedical corpora and kept the
original vocabulary of ALBERT for pre-training.
Sentence embeddings are used for tokenization, and for that,
we pre-processed the data as a sentence text. So every line
in the input text document is a sentence, and an empty line
separates every document. We set the maximum length of each
sentence to 512 words. Shorter sentences were padded to make
512 whereas longer sentences were truncated. Learning rate
of 0.00176 and number of warm-up steps as 3125 for all the
pre-trained versions of the model, except for BioALBERT 1.1
(PubMed +PMC) where the learning rate has been re-adjusted
to 0.00062 (by re-scaling the current learning rate with scaled
1/21.5 times to avoid the problem of exploding loss. Summary
of parameters used in the training process is given in Table I.
We experimented with different settings and found out that
both base and large models were successful with larger batch
size on V3-8 TPU compute instances. We have used two dif-
ferent embedding sizes, i.e., 128 and 256. The 128 embedding
size creates a base model with 12 Million parameters, whereas
a large model has 16 Million parameters with 256 embedding
size. With these combinations, we have presented a total of
four models, given in Table II.
B. Fine-tuning of BioALBERT
Fine-tuning of BioALBERT on BioNER task is presented in
this section. BioNER involves annotating words in a sentence
as named-entities. The labelled datasets that were used for
this task include four categories representing Disease, Species,
Drug/Proteins, and Drugs/Chemicals. The objective is to train
and make a prediction on the labels, which are the proper
nouns within the domain area. More formally, given an input
sentence S = {x1, x2, ..., xz}, where xi is the i-th word and
z represents the length of the sentence. The goal of BioNER
is to classify each word in S and assign it to a corresponding
label y ∈ Y , where Y is a predefined list of all possible label.
Fine-tuning is simple as compared to the pre-training, and
the computational requirements are also not that significant.
TABLE III: Summary of parameters used in fine-tuning
Summary of All parameters used: (Fine Tuning)
Name BioNER
Optimizer adamw
Train Batch Size 32
Eval Batch Size 16
Save Checkpoint 200
Max Seq Length 512
Learning Rate 1.00E-05
Training Steps 5336
Warmup Steps 320
BioALBERT which takes less physical memory and impro-
vised parameter sharing techniques. The BioNER fine-tuning
is trained to learn the word embeddings using the sentence
piece tokenization while the BioBERT model was based on the
word piece embeddings. For each of the pre-trained models,
we constructed a fine-tuning task by using the specific dataset.
The model setup uses the weights of the pre-trained model
that are created previously. We have used 1e-5 learning rate,
batch size as 32 and lower case texts and finally fine-tuned
for 5336 steps. Pre-trained BioALBERT models were pre-
trained using TPUv3-8. All of the hyper-parameters used are
same as default ALBERT unless stated otherwise. All the
tested datasets contain a list of words along with a label B,
I, and O where B denotes the beginning of an entity, I stands
for inside and is used for all words comprising the entity
except the first one, and O means the absence of an entity.
For our experiments, we used these datasets as-is and passed
to it our pre-trained models for the downstream task. The
adamw optimiser was used with evaluation checkpoint so that
the model will be evaluated at different time intervals using
the holdout development dataset to identify the best model
for final predictions. The predictions were performed on the
test datasets, and the performance is compared with baseline
models that were established previously by calculating the F1
Score, Precision and Recall. The summary of all parameters
used in fine-tuning is given in Table III.
IV. EXPERIMENTAL ANALYSIS
In this section, we present the dataset used, baselines and
results to show the effectiveness of our model.
A. Datasets
Our model is evaluated on eight biomedical NER bench-
mark datasets which contain four types of entities and provided
by Lee et al. [12]. Table IV shows the statistics of the datasets
used. Below we briefly explained each dataset:
• BC5CDR: The Bio-creative community challenge for
the chemical-disease relation extraction task (BC5CDR)
the corpus was made available in a Bio-creative work-
shop [24]. The two sub-tasks of BC5CDR are identify-
ing; (i) chemical and (ii) disease entities from Medline
abstracts.
• BC4CHEMD: This dataset is provided by Bio-Creative
community challenge IV for the development and evalu-
ation of tools for Chemical NER [25]. BC4CHEMDNER
TABLE IV: Statistics of the BioNER datasets
Entitity Type Dataset # of Annotations
Disease NCBI Disease 6,881BC5CDR 12,694
Drug/Chem BC5CDR 15,411BC4CHEMD 79,842
Drug/Protein BC2GN 20,703JNLPBA 35,460
SPECIES LINNAEUS 4,077Species-800 3,708
was used for the recognition of chemical compounds and
drugs from Pubmed abstracts.
• NCBI Disease: To promote disease NER-system re-
search, American National Institutes of Health released
the NCBI disease corpus for disease NER-research. The
NCBI disease corpus is large-scale and high-quality; it is
based on the corpus released by Leaman et al. [26].
• JNLPBA: We also used the JNLPBA corpus in our
experiments which are provided by Kim et al. [27]. This
corpus contains five entity types, including DNA, RNA,
Cell Type, Cell Line and Protein.
• BC2GM: BC2GM is provided by Ando [28], the state-
of-the-art system in the Bio-Creative II gene mention
recognition task is a semi-supervised learning method
using alternating structure optimization.
• LINNAEUS: The LINNAEUS corpus was provided by
Gerner et al. [29] which consists of 100 full-text docu-
ments from the PMC Open access document set which
were randomly selected. All mentions of species terms
were manually annotated and normalized to the NCBI
taxonomy IDs of the intended species.
• Species-800: Species-800, which is also known as
S800 [30], is a novel abstract-based manually annotated
corpus. S800 comprises 800 PubMed abstracts in which
organism mentions were identified and mapped to the
corresponding NCBI taxonomy identifiers.
B. Baselines
To assess the performance of the proposed method, an
exhaustive comparison is performed with several advanced
SOTA methodologies along with their published results3. Our
model is compared with the following methods.
Yoon et al. [35] introduced CollaboNet, which consists of
multiple BiLSTM-CRF models, for BioNER. While existing
models were only able to handle datasets with a single entity
type, CollaboNet leverages multiple datasets and achieves the
highest F1 scores. CollaboNet is built upon multiple single-
task NER models (STMs) that send information to each other
for more accurate predictions.
Lou et al. [33] proposed a transition-based model for
joint disease entity-recognition and normalization, based on
transition-based structured prediction framework using struc-
tured perceptron with early-update training and beam-search
3The published results were acquired from respective original publication
TABLE V: Comparison of performance in biomedical named entity recognition (BioNER) task.
Type Datasets Metrics SOTA
BioBERT v1.0 BioBERT v1.0 BioBERT v1.0 BioBERTv1.1 BioALBERT 1.0 BioALBERT 1.0 BioALBERT 1.1 BioALBERT 1.1
(PubMed) (PMC) (PubMed+PMC) (PubMed) (PubMed) (PubMed+PMC) (PubMed) (PubMed+PMC)
Base Base Base Base Base Base Large Large
Disease
NCBI Disease
p 88.30 86.76 86.16 89.04 88.22 97.45 96.84 97.18 97.38
R 89.00 88.02 89.48 89.69 91.25 94.39 94.40 97.18 94.37
F 88.60 87.38 87.79 89.36 89.71 95.89 95.61 97.18 95.85
BC5CDR
p 89.61 85.80 84.67 85.86 86.47 99.69 99.11 99.27 99.39
R 83.09 86.60 85.87 87.27 87.84 95.72 96.17 96.33 95.85
F 86.23 86.2 85.27 86.56 87.15 97.66 97.62 97.78 97.61
Drug/Chem
BC5CDR
p 94.26 92.52 92.46 93.27 93.68 99.99 99.99 99.99 99.99
R 92.38 92.76 92.63 93.61 93.26 95.89 96.24 95.62 95.68
F 93.31 92.64 92.54 93.44 93.47 97.9 98.08 97.76 97.79
BC4CHEMD
p 92.29 91.77 91.65 92.23 92.80 97.76 97.71 97.71 97.88
R 90.01 90.77 90.30 90.61 91.92 94.22 94.83 94.83 94.63
F 91.14 91.26 90.97 91.41 92.36 95.96 96.25 96.25 96.23
Drug/Protein
BC2GM
p 81.81 81.72 82.86 85.16 84.32 97.86 97.84 98.26 98.02
R 81.57 83.38 84.21 83.65 85.12 94.87 94.27 95.72 94.70
F 81.69 82.54 83.53 84.40 84.72 96.34 96.02 96.97 96.33
JNLPBA
p 74.43 71.11 71.17 72.68 72.24 85.14 85.60 86.23 85.56
R 83.22 83.11 82.76 83.21 83.56 80.43 80.98 81.90 81.49
F 78.58 76.65 76.53 77.59 77.49 82.72 83.22 84.01 83.53
Species
LINNAEUS
p 92.80 91.83 91.62 93.84 90.77 99.95 99.98 99.98 99.92
R 94.29 84.72 85.48 86.11 85.83 99.47 99.44 99.48 99.55
F 93.54 88.13 88.45 89.81 88.24 99.71 99.72 99.73 99.73
Species-800
p 74.34 70.60 71.54 72.84 72.80 99.17 98.93 99.10 98.75
R 75.96 75.75 74.71 77.97 75.36 98.34 98.04 98.95 98.69
F 74.98 73.08 73.09 75.31 74.06 98.76 98.49 99.02 98.72
Notes: Precision (P), Recall (R) and F1 (F) scores on each dataset are reported. The best scores are in bold, and the second best scores are underlined. We list the scores of the
state-of-the-art (SOTA) models on different datasets as follows: scores of Xu et al. [31] on NCBI Disease, scores of Sachan et al. [32] on BC2GM, scores of Lou et al. [33] on
BC5CDR-disease, scores of Luo et al. [34] on BC4CHEMD, scores of Yoon et al. [35] on BC5CDR-chemical and JNLPBA and scores of Giorgi and Bader [36] on LINNAEUS
and Species-800
decoding. In another study, Lou et al. [34] proposed a neu-
ral network approach, i.e. attention-based bidirectional Long
Short-Term Memory with a conditional random field layer
(Att-BiLSTM-CRF), to document level chemical NER. The
method leverages document-level global information obtained
by attention mechanism to enforce tagging consistency across
multiple instances of the same token in a document. It achieves
better performances with little feature engineering.
Xu et al. [31] proposed a novel dictionary-based and
document-level attention mechanism with a deep neural net-
work NER method, named as DABLC. DABLC tags the con-
sistency of multiple instances in a document at the document
level and combines an external disease dictionary that is con-
structed with five disease resources containing a rich collection
of disease entities. The authors adopted the efficient exact
string matching method for dictionary matching; this method
can effectively and accurately match the disease names.
Lee et al. [12] introduced BioBERT, which is a pre-trained
language model for biomedical text mining. Authors showed
that pre-training BERT on biomedical corpora is crucial in
applying it to the biomedical domain. BioBERT outperforms
previous models on biomedical text mining tasks such as NER,
RE and QA. We compare BioALBERT with both BioBERT
(v1.0 and V1.1) models and other SOTA models used in
BioNER task. We selected those methods because they are the
SOTA, and based on the conducted meta-analysis exhibit the
highest performance among the techniques so far developed.
C. Results
Table V presents the performance of all the variants of
BioALBERT and contrasts them to baseline methodologies.
Our model outperforms all other methods on all eight datasets
and entity types. For, (i) Disease-type datasets, BioAL-
BERT improved the performance by 7.47% and 10.63% for
NCBI-Disease and BC5CDR-Disease datasets respectively;
(ii) Drug/Chem type datasets increase in performance by
4.61% and 3.89% for BC5CDR-Chem and BC4CHEMD
datasets respectively; (iii) Gene/Protein type datasets increase
in performance by 12.25% and 6.42% for BC2GM and
JNLPBA datasets respectively and; (iv) Species type datasets
increase in performance by 6.19% and 23.71% respectively is
observed.
We have performed multiple comparisons to analyse the
effectiveness of BioALBERT. Fig. 2 presents, the performance
comparison of the same versions (trained on same corpora
and for the same number of steps) of both BioALBERT and
BioBERT. We can see that in Fig. (2a), we compared BioBERT
v1.0-base model which is trained on PubMed with BioAL-
BERT 1.0-base model trained on Pubmed and similarly in
Fig. (2b), we compared BioBERT v1.0-base model trained on
Pubmed and PMC with BioALBER 1.0-base model trained on
PubMed and PMC biomedical corpora. In both cases, BioAL-
BERT outperformed BioBERT on all eight datasets. We also
compared the training time of BioALBERT with BioBERT.
We found that all models BioALBERT beat BioBERT with a
considerable margin. The run time statistics of both pre-trained
models are given in Fig. 3.
D. Discussions
BioALBERT gives better performance and addresses the
previously mentioned challenges in the biomedical domain.
We attribute this to the BioALBERT built on top of the
Fig. 2: Comparison of a) BioBERT v1.0 (Pubmed)-Base v/s BioALBERT 1.0 (Pubmed)-Base ; b) BioBERT v1.0(Pubmed+PMC)-Base v/s BioALBERT 1.0(Pubmed+PMC)-Base
Fig. 3: Comparison of run-time statistics of BioALBERT v/s BioBERT
transformer-based language model that learns contextual re-
lations between words (or subwords) in a text. As opposed
to directional models, which read the text input sequentially
(left-to-right or right-to-left), the transformer encoder reads the
entire sequence of words at once. This characteristic allows
the model to learn the context of a word based on all of its
surroundings (left and right of the word) and address the issue
of contextual representation.
Our model addresses the shortcomings of BERT based
biomedical models. At first, BioALBERT uses cross-layer
parameter sharing and reduces 110 million parameters of
12-layer BERT-base model to 31 million parameters while
keeping the same number of layers and hidden units by
learning parameters for the first block and reuse the block in
the remaining 11 layers. Secondly, our model uses the SOP,
which takes two segments from the training corpus that appear
consecutively and constructs a random pair of segments from
different documents. This enables the model to learn about
discourse-level coherence characteristics from a finer-grained
distinction and leads to better learning representation in down-
stream tasks. Thirdly, our model uses factorized embedding
parameterization in which a smaller size layer vocabulary
and hidden layer to decompose the embedding matrix into
two small matrices which reduce the number of parameters
between vocabulary and the first hidden layer whereas in
BERT based biomedical models embedding size is equal to
the size of the hidden layer. Furthermore, finally, our model
is trained on massive biomedical corpora to be effective on
BioNER to address the issue of the shift of word distribution
from general domain corpora to biomedical corpora. All these,
when combined, address all the issues associated with BioNER
earlier. As our model offers a consistent improvement over all
other methods for all tested datasets, we can conclude that it
is a robust solution for BioNER.
To extend our analysis, we analysed the performance of
different pre-trained models of BioALBERT. We found out
that the performance of all BioALBERT models are almost
equally good, but BioALBERT 1.1-large trained on PubMed
works better than others (shown in Fig. 4). BioALBERT 1.1-
large model, which is trained on PubMed with dup-factor as
five performs better on most of the datasets. This shows that
the relevance of duplication data in NLP tasks.
Fig. 4: Comparison of different variants BioALBERT models
V. CONCLUSION
In this study, we presented BioALBERT, which is a pre-
trained language model for biomedical named entity recog-
nition. We presented four different variants of BioALBERT
models which are trained on huge biomedical corpora for a
different number of steps. We showed that training ALBERT
on biomedical corpora is a crucial step in applying it to
BioNER. As future works, we plan to pre-trained other ver-
sions which include hybrid of general and biomedical corpora
of ALBERT on biomedical corpora with more training steps
and fine-tune on biomedical text mining task. We also plan to
fine-tune BioALBERT on other text mining tasks to show the
effectiveness of our model.
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